已收盘 05-15 16:00:00 美东时间
-0.370
-2.26%
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Aviat Networks业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 第三季度总收入1.00亿美元,同比下降11.2%(去年同期1.126亿美元)。九个月累计收入3.188亿美元,与去年同期3.193亿美元基本持平。地区分布方面,北美占46.2%(4620万美元),国际市场占53.8%(5380万美元)。 **盈利能力:** 毛利率表现疲软,GAAP毛利率29.3%,non-GAAP毛利率29.4%,均显著低于去年同期的34.9%和35.8%。调整后EBITDA为440万美元,占收入的4.4%,同比下降。 *
05-06 12:01
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
无线传输设备制造商Aviat Networks周二股价暴跌,因公司大幅下调全年业绩指引,并将原因归咎于中东冲突导致的项目延迟及部分一级客户需求疲软。 公...
05-05 23:31
On Monday, Aviat Networks (NASDAQ:AVNW) discussed third-quarter financial resul...
05-05 05:55
Aviat Networks shares are trading lower after the company reported worse-than-e...
05-05 04:54
Aviat Networks (NASDAQ:AVNW) lowers FY2026 sales outlook from $440.000 million-$460.000 million to $428.000 million-$440.000 million vs $449.531 million estimate.
05-05 04:12
Aviat Networks (NASDAQ:AVNW) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.44 by 86.36 percent. This is a 93.18 percent decrease over earnings of $0.88 per share from
05-05 04:12
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
A new short report alleges Aviat Networks is not generating earnings it reports and accuses the company of accounting irregularities.
04-01 22:07